|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||188.27 g/mol g·mol−1|
|3D model (JSmol)|
RJR-2429 is a drug that acts as an agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. RJR-2429 is stronger than nicotine but weaker than epibatidine in most assays, and with high affinity for both α3β4 and α4β2 subtypes, as well as the less studied α1βγδ subtype.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|